Effects of a monoclonal anti‐acetylcholine receptor antibody on the avian end‐plate.
- 31 March 1989
- journal article
- research article
- Published by Wiley in The Journal of Physiology
- Vol. 411 (1) , 271-283
- https://doi.org/10.1113/jphysiol.1989.sp017573
Abstract
1. The effects of anti-acetylcholine receptor (AChR) monoclonal antibodies (mAbs) 370 and 132A on miniature end-plate potentials (MEPPs) and end-plate currents (EPCs) in the posterior latissimus dorsi muscle of adult chickens were investigated. 2. After incubation of the electrophysiological preparation with mAb 370 (5-50 .mu.g/ml), which blocks both agonist (carbamycholine) and .alpha.-bungarotoxin (.alpha.-BTX) binding and induces a hyperacute form of experimental autoimmune myasthenia gravis (EMAG), MEPP and EPC amplitudes were irreversible reduced. 3. This effect was not associated with any significant change in the time constant describing EPC decay (.tau.EPC), current reversal potential, or the voltage dependence of .tau.EPC. The .tau.EPC at -80 mV was 5.9 .+-. 0.6 ms before incubation with mAb 370 (50 .mu.g/ml) and 6.0 .+-. 0.9 ms afterwards. Current reversal potential was -3.9 .+-. 0.4 mV before mAb incubation and -4.8 .+-. 1.5 mV afterwards. The change in membrane potential required to produce an e-fold change in .tau.EPC was 128 .+-. 2.3 mV before antibody incubation compared to 125 .+-. 6.6 mV after incubation. 4. A second anti-AChR mAb, 132A (50 .mu.g/ml), which is capable of inducing the classically described form of EAMG without blocking agonist of .alpha.-BTX binding, or inducing hperacute EMG, produced no significant change in MEPP amplitude, EPC amplitude, .tau.EPC or EPC reversal potentials. 5. The mAb 370 (50 .mu.g/ml) induced a partially reversible decrease of quantal content of the neurally evoked end-plate potential (EPP). This effect was not observed with mAb 132A, (+)tubocurarine (10-7-10-5 g/ml0 or an inrrelevant antioestrogen receptor mAb. 6. This data suggest that the rapid onset of weakness observed in chicken hatchlings after the injection of mAb 370 (Gomez and Richman,1983) can be attributed to a combined effect of a block of acetylcholine (ACh)-induced ion channel activity in the postsynatpic membrane and a reduction of the neurally evoked release of acetylcholine from the nerve terminal.This publication has 43 references indexed in Scilit:
- Monoclonal antibodies modify acetylcholine-induced ionic channel properties in cultured chick myoballsThe Journal of Membrane Biology, 1983
- Organization of ligand binding sites at the acetylcholine receptor: a study with monoclonal antibodiesBiochemistry, 1983
- Functional Activities of Autoantibodies to Acetylcholine Receptors and the Clinical Severity of Myasthenia GravisNew England Journal of Medicine, 1982
- MONOCLONAL HYBRIDOMA ANTI‐ACETYLCHOLINE RECEPTOR ANTIBODIES: ANTIBODY SPECIFICITY AND EFFECT OF PASSIVE TRANSFER*Annals of the New York Academy of Sciences, 1981
- A re-examination of curare action at the motor endplateProceedings of the Royal Society of London. B. Biological Sciences, 1978
- Human myasthenic sera reduce acetylcholine sensitivity of human muscle cells in tissue cultureNature, 1977
- Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automimmune myasthenia gravis.The Journal of Experimental Medicine, 1976
- Membrane cable properties of normal and dystrophic chicken muscle fibersExperimental Neurology, 1975
- Experimental autoimmune myasthenia: A model of myasthenia gravis in rats and guinea pigs.The Journal of Experimental Medicine, 1975
- Autoimmune Response to Acetylcholine ReceptorScience, 1973